An ORA Capital Partners non-exec has invested more than £15,000 in the company.
James Ede-Golightly bought 19,176 shares for his SIPP at 80p each. This takes his stake in AIM-quoted ORA to 199,176 shares.
Cambridge graduate Ede-Golightly is a former analyst with Merrill Lynch and Commerzbank.
Start your trial of MoneyWeek today
Get unparalleled financial insight, analysis and expert opinion you can profit from.
Start your trial
Sign up for MoneyWeek’s free twice-daily newsletter.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
Join more than 165,000 subscribers and keep yourself informed with latest financial news, insights and expert analysis to help you understand what really matters when it comes to your finances.
ORA is an investment company specialising in taking significant stakes in developing companies. It has developed five main businesses: Nanoco, Oxford Advanced Surfaces, Tissue Regenix, Oxford Nutrascience and Obtala Resources. All of these are quoted on AIM. ORA also has a stake in broker Novum Securities.
Latest Videos FromMoneyWeek
ORA reported a fall in interim profit from £22.2m to £11.5m in the six months to July 2010. The net asset value fell slightly from £127m to £124.8m having bought back £13.7m worth of shares at 100p each.
Top Director Buys
ORA Capital Partners Ltd. (ORA) Director name: Mr James Ede-GolightlyAmount purchased: 19,176 @ 80.00p Value: £15,341
Top Director Sells
Goodwin Plc (GDWN) Director name: Mr John W GoodwinAmount sold: 12,946 @ 1,230.00p Value: £159,236
Goodwin Plc (GDWN) Director name: Mr Richard S GoodwinAmount sold: 8,478 @ 1,230.00p Value: £104,279
Goodwin Plc (GDWN) Director name: Mr Richard S GoodwinAmount sold: 8,478 @ 1,230.00p Value: £104,279
Goodwin Plc (GDWN) Director name: Mr Matthew Stanley GoodwinAmount sold: 6,270 @ 1,230.00p Value: £77,121
